Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 34

1.

Successes and challenges for preventing measles, mumps and rubella by vaccination.

Bankamp B, Hickman C, Icenogle JP, Rota PA.

Curr Opin Virol. 2019 Feb;34:110-116. doi: 10.1016/j.coviro.2019.01.002. Epub 2019 Mar 7. Review.

PMID:
30852425
2.

Use of FTA Cards To Transport Throat Swabs and Oral Fluid Samples for Molecular Detection and Genotyping of Measles and Rubella Viruses.

Bankamp B, Sein C, Pukuta Simbu E, Anderson R, Abernathy E, Chen MH, Muyembe Tamfum JJ, Wannemuehler KA, Waku-Kouomou D, Lopareva EN, Icenogle JP, Rota PA, Goodson JL.

J Clin Microbiol. 2019 Apr 26;57(5). pii: e00048-19. doi: 10.1128/JCM.00048-19. Print 2019 May.

PMID:
30814262
3.

Risk Factors for Measles Virus Infection Among Adults During a Large Outbreak in Postelimination Era in Mongolia, 2015.

Hagan JE, Takashima Y, Sarankhuu A, Dashpagma O, Jantsansengee B, Pastore R, Nyamaa G, Yadamsuren B, Mulders MN, Wannemuehler KA, Anderson R, Bankamp B, Rota P, Goodson JL.

J Infect Dis. 2017 Dec 5;216(10):1187-1195. doi: 10.1093/infdis/jix449.

PMID:
29040627
4.

Complete Genome Sequences of Mumps and Measles Virus Isolates from Three States in the United States.

Magaña LC, Espinosa A, Marine RL, Ng TFF, Castro CJ, Montmayeur AM, Hacker JK, Scott S, Whyte T, Bankamp B, Oberste MS, Rota PA.

Genome Announc. 2017 Aug 17;5(33). pii: e00748-17. doi: 10.1128/genomeA.00748-17.

5.

Perspective on Global Measles Epidemiology and Control and the Role of Novel Vaccination Strategies.

Coughlin MM, Beck AS, Bankamp B, Rota PA.

Viruses. 2017 Jan 19;9(1). pii: E11. doi: 10.3390/v9010011. Review.

6.

Rapid Identification of Measles Virus Vaccine Genotype by Real-Time PCR.

Roy F, Mendoza L, Hiebert J, McNall RJ, Bankamp B, Connolly S, Lüdde A, Friedrich N, Mankertz A, Rota PA, Severini A.

J Clin Microbiol. 2017 Mar;55(3):735-743. doi: 10.1128/JCM.01879-16. Epub 2016 Nov 16.

7.

Measles immunity among pregnant women aged 15-44 years in Namibia, 2008 and 2010.

Cardemil CV, Jonas A, Beukes A, Anderson R, Rota PA, Bankamp B, Gary HE Jr, Sawadogo S, Patel SV, Zeko S, Muroua C, Gaeb E, Wannemuehler K, Gerber S, Goodson JL.

Int J Infect Dis. 2016 Aug;49:189-95. doi: 10.1016/j.ijid.2016.05.020. Epub 2016 May 24.

8.

Rubella immunity among pregnant women aged 15-44 years, Namibia, 2010.

Jonas A, Cardemil CV, Beukes A, Anderson R, Rota PA, Bankamp B, Gary HE Jr, Sawadogo S, Patel SV, Zeko S, Muroua C, Gaeb E, Wannemuehler K, Gerber S, Goodson JL.

Int J Infect Dis. 2016 Aug;49:196-201. doi: 10.1016/j.ijid.2016.05.009. Epub 2016 May 16.

9.

Whole-Genome Sequencing During Measles Outbreaks.

Rota PA, Bankamp B.

J Infect Dis. 2015 Nov 15;212(10):1529-30. doi: 10.1093/infdis/jiv272. Epub 2015 Jul 6. No abstract available.

PMID:
26153410
10.

Wild-type measles viruses with non-standard genome lengths.

Bankamp B, Liu C, Rivailler P, Bera J, Shrivastava S, Kirkness EF, Bellini WJ, Rota PA.

PLoS One. 2014 Apr 18;9(4):e95470. doi: 10.1371/journal.pone.0095470. eCollection 2014.

11.

Improving molecular tools for global surveillance of measles virus.

Bankamp B, Byrd-Leotis LA, Lopareva EN, Woo GK, Liu C, Jee Y, Ahmed H, Lim WW, Ramamurty N, Mulders MN, Featherstone D, Bellini WJ, Rota PA.

J Clin Virol. 2013 Sep;58(1):176-82. doi: 10.1016/j.jcv.2013.05.018. Epub 2013 Jun 24.

12.

Genetic characterization of measles vaccine strains.

Bankamp B, Takeda M, Zhang Y, Xu W, Rota PA.

J Infect Dis. 2011 Jul;204 Suppl 1:S533-48. doi: 10.1093/infdis/jir097.

PMID:
21666210
13.

Improving global virologic surveillance for measles and rubella.

Rota PA, Brown KE, Hübschen JM, Muller CP, Icenogle J, Chen MH, Bankamp B, Kessler JR, Brown DW, Bellini WJ, Featherstone D.

J Infect Dis. 2011 Jul;204 Suppl 1:S506-13. doi: 10.1093/infdis/jir117.

PMID:
21666207
14.

Target analysis of the experimental measles therapeutic AS-136A.

Yoon JJ, Krumm SA, Ndungu JM, Hoffman V, Bankamp B, Rota PA, Sun A, Snyder JP, Plemper RK.

Antimicrob Agents Chemother. 2009 Sep;53(9):3860-70. doi: 10.1128/AAC.00503-09. Epub 2009 Jun 15.

15.

Adaptation to cell culture induces functional differences in measles virus proteins.

Bankamp B, Fontana JM, Bellini WJ, Rota PA.

Virol J. 2008 Oct 27;5:129. doi: 10.1186/1743-422X-5-129.

16.

Inhibition of interferon induction and signaling by paramyxoviruses.

Fontana JM, Bankamp B, Rota PA.

Immunol Rev. 2008 Oct;225:46-67. doi: 10.1111/j.1600-065X.2008.00669.x. Review.

PMID:
18837775
17.

Genetic variability and mRNA editing frequencies of the phosphoprotein genes of wild-type measles viruses.

Bankamp B, Lopareva EN, Kremer JR, Tian Y, Clemens MS, Patel R, Fowlkes AL, Kessler JR, Muller CP, Bellini WJ, Rota PA.

Virus Res. 2008 Aug;135(2):298-306. doi: 10.1016/j.virusres.2008.04.008. Epub 2008 May 19.

PMID:
18490071
18.

The C, V and W proteins of Nipah virus inhibit minigenome replication.

Sleeman K, Bankamp B, Hummel KB, Lo MK, Bellini WJ, Rota PA.

J Gen Virol. 2008 May;89(Pt 5):1300-8. doi: 10.1099/vir.0.83582-0.

PMID:
18420809
19.

Regulation of interferon signaling by the C and V proteins from attenuated and wild-type strains of measles virus.

Fontana JM, Bankamp B, Bellini WJ, Rota PA.

Virology. 2008 Apr 25;374(1):71-81. doi: 10.1016/j.virol.2007.12.031. Epub 2008 Jan 29.

20.

Genetic changes that affect the virulence of measles virus in a rhesus macaque model.

Bankamp B, Hodge G, McChesney MB, Bellini WJ, Rota PA.

Virology. 2008 Mar 30;373(1):39-50. Epub 2007 Dec 21.

21.

The genomic termini of wild-type and vaccine strains of measles virus.

Liu X, Bankamp B, Xu W, Bellini WJ, Rota PA.

Virus Res. 2006 Dec;122(1-2):78-84. Epub 2006 Aug 4. Erratum in: Virus Res. 2007 Sep;128(1-2):164-5.

PMID:
16889863
22.

Genetic characterization of Nipah virus, Bangladesh, 2004.

Harcourt BH, Lowe L, Tamin A, Liu X, Bankamp B, Bowden N, Rollin PE, Comer JA, Ksiazek TG, Hossain MJ, Gurley ES, Breiman RF, Bellini WJ, Rota PA.

Emerg Infect Dis. 2005 Oct;11(10):1594-7.

24.

Ultrastructural characterization of SARS coronavirus.

Goldsmith CS, Tatti KM, Ksiazek TG, Rollin PE, Comer JA, Lee WW, Rota PA, Bankamp B, Bellini WJ, Zaki SR.

Emerg Infect Dis. 2004 Feb;10(2):320-6.

25.

Real-time reverse transcription-polymerase chain reaction assay for SARS-associated coronavirus.

Emery SL, Erdman DD, Bowen MD, Newton BR, Winchell JM, Meyer RF, Tong S, Cook BT, Holloway BP, McCaustland KA, Rota PA, Bankamp B, Lowe LE, Ksiazek TG, Bellini WJ, Anderson LJ.

Emerg Infect Dis. 2004 Feb;10(2):311-6.

26.

Nipah virus conforms to the rule of six in a minigenome replication assay.

Halpin K, Bankamp B, Harcourt BH, Bellini WJ, Rota PA.

J Gen Virol. 2004 Mar;85(Pt 3):701-7.

PMID:
14993656
27.

Characterization of a novel coronavirus associated with severe acute respiratory syndrome.

Rota PA, Oberste MS, Monroe SS, Nix WA, Campagnoli R, Icenogle JP, Peñaranda S, Bankamp B, Maher K, Chen MH, Tong S, Tamin A, Lowe L, Frace M, DeRisi JL, Chen Q, Wang D, Erdman DD, Peret TC, Burns C, Ksiazek TG, Rollin PE, Sanchez A, Liffick S, Holloway B, Limor J, McCaustland K, Olsen-Rasmussen M, Fouchier R, Günther S, Osterhaus AD, Drosten C, Pallansch MA, Anderson LJ, Bellini WJ.

Science. 2003 May 30;300(5624):1394-9. Epub 2003 May 1.

28.

Activity of polymerase proteins of vaccine and wild-type measles virus strains in a minigenome replication assay.

Bankamp B, Kearney SP, Liu X, Bellini WJ, Rota PA.

J Virol. 2002 Jul;76(14):7073-81.

29.

Comparison of L proteins of vaccine and wild-type measles viruses.

Bankamp B, Bellini WJ, Rota PA.

J Gen Virol. 1999 Jul;80 ( Pt 7):1617-25.

PMID:
10423129
30.

Domains of the measles virus N protein required for binding to P protein and self-assembly.

Bankamp B, Horikami SM, Thompson PD, Huber M, Billeter M, Moyer SA.

Virology. 1996 Feb 1;216(1):272-7.

31.

An amino-proximal domain of the L protein binds to the P protein in the measles virus RNA polymerase complex.

Horikami SM, Smallwood S, Bankamp B, Moyer SA.

Virology. 1994 Dec;205(2):540-5.

PMID:
7975255
32.

Susceptibility to measles virus-induced encephalitis in mice correlates with impaired antigen presentation to cytotoxic T lymphocytes.

Niewiesk S, Brinckmann U, Bankamp B, Sirak S, Liebert UG, ter Meulen V.

J Virol. 1993 Jan;67(1):75-81.

33.

Efficacy of individual measles virus structural proteins in the protection of rats from measles encephalitis.

Brinckmann UG, Bankamp B, Reich A, ter Meulen V, Liebert UG.

J Gen Virol. 1991 Oct;72 ( Pt 10):2491-500.

PMID:
1833505
34.

Measles virus nucleocapsid protein protects rats from encephalitis.

Bankamp B, Brinckmann UG, Reich A, Niewiesk S, ter Meulen V, Liebert UG.

J Virol. 1991 Apr;65(4):1695-700.

Supplemental Content

Loading ...
Support Center